GAVI alliance offers matched funds for GSK malaria vaccine pilot

The GAVI global vaccine alliance has offered funding of up to US$27.5 million for pilot tests of GlaxoSmithKline’s first-generation malaria vaccine, but only if other organizations promise to match that commitment.
Go to Source